Amrita is an infectious diseases specialist with an interest in equity in health care, global health, combating antimicrobial resistance, rational use of antimicrobials, tuberculosis programming and health systems strengthening.
She has more than ten years of clinical experience and holds an appointment as staff specialist at Royal Prince Alfred Hospital, Sydney where she is also clinical co lead of the Antimicrobial Stewardship program.
She has previously worked in PNG, Sierra Leone and Uzbekistan across various roles including clinical care, research and health systems strengthening.
The Medical Journal of Australia
Amrita Ronnachit, Chloe Story, Chloe Story, Amrita Ronnachit, Chloe Story, Amrita Ronnachit
The Medical Journal of Australia
Amrita Ronnachit, Chloe Story, Chloe Story, Amrita Ronnachit, Chloe Story, Amrita Ronnachit
The Medical Journal of Australia
Amrita Ronnachit, Chloe Story, Chloe Story, Amrita Ronnachit, Chloe Story, Amrita Ronnachit
By 2050, antimicrobial resistant bacteria (AMR) could cause 10 million deaths annually. Our collaborative project supports Papua New Guinea’s domestic AMR response.
Burnet Institute is leading the Papua New Guinea Country Grant component of the Fleming Fund, a UK Aid program tackling antimicrobial resistance in low- and middle-income countries.